Klara Fodor
Debrecen, HB 4032, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer.
Journal: Molecules (Basel, Switzerland)
Published: January 26, 2021
Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
Journal: Life (Basel, Switzerland)
Published: November 16, 2020
The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
Journal: Oncotarget
Published: December 05, 2019
Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.
Journal: Molecules (Basel, Switzerland)
Published: May 29, 2018
Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: March 21, 2018
Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.
Journal: OncoTargets and therapy
Published: March 06, 2018
Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Journal: Oncology reports
Published: August 04, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026